LET 2.5 (Letrozole 2.5 mg)
Pill with imprint LET 2.5 is Yellow, Round and has been identified as Letrozole 2.5 mg. It is supplied by Dr. Reddy's Laboratories Limited .
Letrozole is used in the treatment of female infertility; breast cancer, metastatic; breast cancer; breast cancer, adjuvant and belongs to the drug classes aromatase inhibitors, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Letrozole 2.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for LET 2.5
Letrozole
- Imprint:
- LET 2.5
- Strength:
- 2.5 mg
- Color:
- Yellow
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Aromatase inhibitors
Hormones/antineoplastics - Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Dr. Reddy's Laboratories Limited
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
polyethylene glycol
povidone
magnesium silicate
titanium dioxide
ferric oxide yellow
Note: Inactive ingredients may vary.
More about letrozole
- Letrozole Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 126 Reviews
- Drug class: aromatase inhibitors
Consumer resources
Other brands: Femara
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
